Art

J-GLOBAL ID：201402279895209143   Reference number：14A0246059

Comparison of Effects of α-Glucosidase Inhibitors and Glinide Drugs on Endothelial Dysfunction in Diabetic Patients With Coronary Artery Disease

冠動脈疾患のある糖尿病患者において内皮障害に対するαグルコシダーゼ阻害薬とグリニド薬の効果比較

Author (7)： SAWADA Takahiro (Div. of Cardiovascular Medicine, Himeji Brain and Heart Center) ,  SHIOTANI Hideyuki (Dep. of Preventive Medicine, Kobe Univ. Graduate School of Preventive Medicine) ,  TERASHITA Daisuke (Div. of Cardiovascular Medicine, Dep. of Internal Medicine, Hyogo Prefectural Awaji Hospital) ,  NAGASAWA Yoshinori (Div. of Cardiovascular Medicine, Dep. of Internal Medicine, Hyogo Prefectural Awaji Hospital) ,  KIM Su-shiku (Div. of Cardiovascular Medicine, Dep. of Internal Medicine, Hyogo Prefectural Awaji Hospital) ,  KOIDE Masanobu (Koide Clinic) ,  YOKOYAMA Mitsuhiro (Div. of Cardiovascular Medicine, Himeji Brain and Heart Center)
Material： Circulation Journal  (Circ J)
Volume： 78  Issue： 1  Page： 248-255 (J-STAGE)  Publication year： 2014 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： hyperglycemia ,...
Semi thesaurus term： insulin resistance ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0246059&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (2)： Treatment for metabolic diseases,nutritional diseases.  (GD05030F) ,  Clinical medicine on cardiovascular system in general  (GJ01030V)

Substance index (2)： Nateglinide ,  Miglitol

Reference (23)：

•  1. ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011; 364: 818–828.
•  2. Emoto T, Sawada T, Hashimoto M, Kageyama H, Terashita D, Mizoguchi T, et al. Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease. Am J Cardiol 2012; 109: 42–46.
•  3. Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M. The STOP-NIDDM Trial: An international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care 1998; 21: 1720–1725.
•  4. Hanefeld M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: Meta-analysis of seven long-term studies. Eur Heart J 2004; 25: 10–16.
•  5. Hirano M, Nakamura T, Obata JE, Fujioka D, Saito Y, Kawabata K, et al. Early improvement in carotid plaque echogenicity by acarbose in patients with acute coronary syndromes. Circ J 2012; 76: 1452–1460.

Terms in the title (6)： 冠動脈疾患 ,  糖尿病患者 ,  内皮 ,  障害 ,  αグルコシダーゼ阻害薬 ,  グリニド薬